CO4940496A1 - Inhibidores de la proteasa del vih - Google Patents

Inhibidores de la proteasa del vih

Info

Publication number
CO4940496A1
CO4940496A1 CO98014251A CO98014251A CO4940496A1 CO 4940496 A1 CO4940496 A1 CO 4940496A1 CO 98014251 A CO98014251 A CO 98014251A CO 98014251 A CO98014251 A CO 98014251A CO 4940496 A1 CO4940496 A1 CO 4940496A1
Authority
CO
Colombia
Prior art keywords
alkyl
group
cycloalkyl
aryl
acyl
Prior art date
Application number
CO98014251A
Other languages
English (en)
Spanish (es)
Inventor
Albizati Kim
Siegfried Reich
Michael D Varney
E Zhang Kanyin
Kobayashi Takuo
Original Assignee
Agouron Pharma
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma, Japan Tobacco Inc filed Critical Agouron Pharma
Publication of CO4940496A1 publication Critical patent/CO4940496A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CO98014251A 1997-03-13 1998-03-13 Inhibidores de la proteasa del vih CO4940496A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81595197A 1997-03-13 1997-03-13

Publications (1)

Publication Number Publication Date
CO4940496A1 true CO4940496A1 (es) 2000-07-24

Family

ID=25219265

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98014251A CO4940496A1 (es) 1997-03-13 1998-03-13 Inhibidores de la proteasa del vih

Country Status (35)

Country Link
EP (1) EP0970055A2 (hu)
JP (1) JP2001516350A (hu)
KR (1) KR100511089B1 (hu)
CN (1) CN1179948C (hu)
AP (1) AP1358A (hu)
AR (1) AR012556A1 (hu)
AU (1) AU743078B2 (hu)
BG (1) BG63540B1 (hu)
BR (1) BR9808867A (hu)
CA (1) CA2284163A1 (hu)
CO (1) CO4940496A1 (hu)
CZ (1) CZ296647B6 (hu)
EA (1) EA002378B1 (hu)
EE (1) EE04114B1 (hu)
GE (1) GEP20022764B (hu)
HR (1) HRP980112A2 (hu)
HU (1) HUP0001380A3 (hu)
IL (2) IL131870A0 (hu)
IS (1) IS5176A (hu)
MX (1) MXPA99008395A (hu)
MY (1) MY117535A (hu)
NO (1) NO315555B1 (hu)
NZ (1) NZ337706A (hu)
OA (1) OA11196A (hu)
PA (1) PA8448801A1 (hu)
PE (1) PE58799A1 (hu)
PL (1) PL192786B1 (hu)
SA (1) SA98181116B1 (hu)
SK (1) SK283636B6 (hu)
SV (1) SV1998000038A (hu)
TR (1) TR199902508T2 (hu)
TW (1) TW200517112A (hu)
UA (1) UA57772C2 (hu)
WO (1) WO1998040357A2 (hu)
ZA (1) ZA982047B (hu)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
CA2284163A1 (en) 1998-09-17
MXPA99008395A (es) 2003-08-12
UA57772C2 (uk) 2003-07-15
PA8448801A1 (es) 2000-05-24
EP0970055A2 (en) 2000-01-12
BG103727A (en) 2000-04-28
TW200517112A (en) 2005-06-01
EA002378B1 (ru) 2002-04-25
HUP0001380A3 (en) 2001-12-28
BR9808867A (pt) 2000-07-11
KR100511089B1 (ko) 2005-08-31
IS5176A (is) 1999-09-10
AU743078B2 (en) 2002-01-17
HUP0001380A2 (hu) 2000-09-28
IL131870A (en) 2006-04-10
CZ296647B6 (cs) 2006-05-17
JP2001516350A (ja) 2001-09-25
NO315555B1 (no) 2003-09-22
AP9901648A0 (en) 1999-09-30
AU6457598A (en) 1998-09-29
CN1179948C (zh) 2004-12-15
NO994415D0 (no) 1999-09-10
OA11196A (en) 2003-05-21
SV1998000038A (es) 1999-02-15
BG63540B1 (bg) 2002-04-30
IL131870A0 (en) 2001-03-19
WO1998040357A3 (en) 1998-11-26
AR012556A1 (es) 2000-11-08
TR199902508T2 (xx) 2000-02-21
EE04114B1 (et) 2003-08-15
KR20000076236A (ko) 2000-12-26
SK283636B6 (sk) 2003-11-04
NZ337706A (en) 2001-04-27
WO1998040357A2 (en) 1998-09-17
EA199900823A1 (ru) 2000-04-24
CN1253548A (zh) 2000-05-17
PE58799A1 (es) 1999-07-12
HRP980112A2 (en) 1998-12-31
NO994415L (no) 1999-11-10
CZ319199A3 (cs) 2000-06-14
GEP20022764B (en) 2002-08-26
SA98181116B1 (ar) 2006-10-04
MY117535A (en) 2004-07-31
EE9900416A (et) 2000-04-17
SK122299A3 (en) 2000-05-16
PL335672A1 (en) 2000-05-08
PL192786B1 (pl) 2006-12-29
ZA982047B (en) 1998-09-28
AP1358A (en) 2004-12-03

Similar Documents

Publication Publication Date Title
CO4970713A1 (es) Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
ATE168677T1 (de) Retroviralproteasehemmende verbindungen
AR025386A1 (es) Moduladores de los receptores activados del proliferador de peroxisomas
AR037898A1 (es) Compuesto de benzamida, uso de un compuesto de benzamida en la fabricacion de un medicamento, proceso para su preparacion y composicion farmaceutica que lo comprende
ATE184194T1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)- homoserinlacton
CO5611195A2 (es) Novedosos inhibidores de la gamma secretasa
ES2051772T3 (es) 2-sustituido-e-fusionado-(1,2,4)-triazol(1,5-c)pirimidinas, composiciones farmaceuticas y sus usos.
NO178541C (no) Farmakologisk virksomme hydrazinderivater
CO4980859A1 (es) Arilpiperazinas que tienen actividad sobre el receptor 1a de la serotonina
ES2195933T3 (es) Nuevos derivados de flavonas, xantonas y cumarinas.
CO4950567A1 (es) Inhibidores de proteasas dores de proteasas.
PT1468692E (pt) Utilizacao de 2,6-dialquil-4-sililfenois para o tratamento do xantoma
FI884088A (fi) Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat.
AR012990A1 (es) Compuestos de benzo(5,6) cicloheptapiridina, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos como inhibidores de laproteina farnesil transferasa.
CO4940496A1 (es) Inhibidores de la proteasa del vih
FI800224A (fi) 2-hydroxi-naftalinderivat och anvaendningen av dessa som kopplingskomponenter i diazotypiefieringsmaterial
MX9302165A (es) Derivados de benzoxazinona y benzothiazinona y composiciones farmaceuticas que los comprende
ES2155655T3 (es) Compuestos de benzotiofeno, usos y formulaciones de los mismos.
CO5180536A1 (es) Inhibidores de proteasas catepsina
CO4950554A1 (es) Derivados de 1,3-dihidro o 3,4-dihidroisoquinolin-benzamida
SE8502317D0 (sv) Cefalosporinantibiotika
DK0435235T3 (da) Nye isoquinolinderivater og salte deraf
EA200400667A3 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
PE20020610A1 (es) Compuestos hidroxietilamina tripeptidos mimeticos como inhibidores de la aspartil proteasa de vih
CO4780021A1 (es) Derivados de butadieno y procedimiento para la preparacion de los mismos